Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

作者: P Fenaux , MC Le Deley , S Castaigne , E Archimbaud , C Chomienne

DOI: 10.1182/BLOOD.V82.11.3241.3241

关键词:

摘要: We designed a multicenter randomized trial comparing chemotherapy with daunorubicin-Ara C (chemotherapy group) and all transretinoic acid (ATRA) combined to the same (ATRA in newly diagnosed APL patients aged 65 years or less. The major endpoint of study was event-free survival (EFS) (“events” being defined as failure achieve complete remission [CR], occurrence relapse, death CR). Early termination decided after first interim analysis, EFS significantly higher ATRA group. At time, 101 had been (54 group 47 group). In group, 49 (91%) achieved CR, 5 (9%) early death, 0 resistant leukemia, compared 38 (81%), 4 (8%), (10%) patients, respectively, difference CR rate between two groups not significant. duration coagulopathy reduced six relapsed 7 15.5 months. 12 1 16 months, 2 died CR. Kaplan-Meier estimated at 79% +/- 7% 50% 9% (P = .001). estimate relapse 19% 8% 40% 12% months .005). conclusion, followed by increases APL. These results strongly suggest that should be incorporated front line therapy

参考文章(38)
Pierre Fenaux, Sylvie Castaigne, Herve Dombret, Eric Archimbaud, Monica Duarte, Pierre Morel, Thierry Lamy, Herve Tilly, Agnes Guerci, Frederic Maloisel, None, All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood. ,vol. 80, pp. 2176- 2181 ,(1992) , 10.1182/BLOOD.V80.9.2176.2176
S Elliott, K Taylor, S White, R Rodwell, P Marlton, D Meagher, J Wiley, D Taylor, S Wright, P Timms, Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis Blood. ,vol. 79, pp. 1916- 1919 ,(1992) , 10.1182/BLOOD.V79.8.1916.1916
Jean Bernard, Marise Weil, Michel Boiron, Claude Jacquillat, Georges Flandrin, Marie-François Gemon, Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin Blood. ,vol. 41, pp. 489- 496 ,(1973) , 10.1182/BLOOD.V41.4.489.489
ME Huang, YC Ye, SR Chen, JR Chai, JX Lu, L Zhoa, LJ Gu, ZY Wang, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood. ,vol. 72, pp. 567- 572 ,(1988) , 10.1182/BLOOD.V72.2.567.567
Hagop M. Kantarjian, Michael J. Keating, Ronald S. Walters, Elihu H. Estey, Kenneth B. McCredie, Terry L. Smith, Willard T. Dalton, Ann Cork, Jose M. Trujillo, Emil J Freireich, Acute promyelocytic leukemia The American Journal of Medicine. ,vol. 80, pp. 789- 797 ,(1986) , 10.1016/0002-9343(86)90617-0
Miguel A Sanz, Isidro Jarque, Guillermo Martín, Ignacio Lorenzo, Jesús Martínez, Javier Rafecas, Emilio Pastor, María José Sayas, Guillermo Sanz, Federico Gomis, None, Acute promyelocytic leukemia.Therapy results and prognostic factors Cancer. ,vol. 61, pp. 7- 13 ,(1988) , 10.1002/1097-0142(19880101)61:1<7::AID-CNCR2820610103>3.0.CO;2-6
A Kakizuka, WH Miller Jr, K Umesono, RP Warrell Jr, Stanley R Frankel, VVVS Murty, E Dmitrovsky, RM Evans, None, Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML Cell. ,vol. 66, pp. 663- 674 ,(1991) , 10.1016/0092-8674(91)90112-C
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25